HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Estrogens protect myocardium against ischemia/reperfusion insult by up-regulation of CRH receptor type 2 in female rats.

AbstractBACKGROUND:
The mechanism underlying estrogen cardioprotection remains largely unknown. Urocortin (UCN), a member of corticotropin-releasing hormone (CRH) family, is one of endogenous cardioprotective factors. The goal of present study is to investigate whether estrogens regulate UCN and its receptor CRH receptor type 2 (CRHR2) in female rat heart.
METHODS:
17β-estradiol (E2) was subcutaneously administrated to ovariectomized (OVX) rats for eight weeks. UCN was administrated before simulated myocardial ischemia/reperfusion (I/R). Cell damage was assessed by measurement of infarct size, activity of serum creatine kinase (CK) and lactate dehydrogenase (LDH) and percentage of TUNEL staining in myocardium. The mRNA and protein levels of UCN and CRHR2 were determined in sham operated and OVX rats with or without E2 replacement. DNA methylation frequency of CRHR2 gene promoter was determined by bisulfite-sequencing.
RESULTS:
UCN administration reduced infarct size, LDH and CK level and percentage of TUNEL staining upon I/R injury. The cardioprotective effects of UCN were abrogated in OVX rats and E2 replacement restored UCN-induced cardioprotection.CRHR2 mRNA and protein expression were down-regulated more than 40% in OVX rats, both of which were restored by E2 replacement. UCN mRNA and protein levels were not affected by ovariectomy and E2 replacement. Hypermethylation in CRHR2 promoter was found in OVX rats, and two of the methylated CpG sites were seated at cis-acting elements. Hypermethylation induced by OVX could also be ameliorated by E2 replacement.
CONCLUSION:
Estrogens maintain CRHR2 expression in myocardium, which may through an epigenetic mechanism, and enhance UCN-induced cardioprotective effects against I/R injury.
AuthorsBinhai Cong, Xiaoyan Zhu, Buqing Cao, Jian Xiao, Zhinong Wang, Xin Ni
JournalInternational journal of cardiology (Int J Cardiol) Vol. 168 Issue 5 Pg. 4755-60 (Oct 12 2013) ISSN: 1874-1754 [Electronic] Netherlands
PMID23962778 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2013.
Chemical References
  • CRF receptor type 2
  • Estrogens
  • RNA, Messenger
  • Receptors, Corticotropin-Releasing Hormone
  • Urocortins
  • Estradiol
Topics
  • Animals
  • Apoptosis (drug effects)
  • Blotting, Western
  • Disease Models, Animal
  • Estradiol (administration & dosage)
  • Estrogen Replacement Therapy (methods)
  • Estrogens (administration & dosage)
  • Female
  • Gene Expression Regulation
  • Gene Frequency
  • In Situ Nick-End Labeling
  • Injections, Subcutaneous
  • Myocardial Reperfusion Injury (genetics, metabolism, prevention & control)
  • Myocardium (metabolism, pathology)
  • Ovariectomy (adverse effects)
  • RNA, Messenger (genetics)
  • Rats
  • Rats, Sprague-Dawley
  • Real-Time Polymerase Chain Reaction
  • Receptors, Corticotropin-Releasing Hormone (biosynthesis, genetics)
  • Urocortins (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: